Nuevocor Pte.
Latest round
- Series B
Last raised
- Sep 2025
Total raised
- $50M
Investors
- 10
About Nuevocor Pte.
Founded in 2021 and based in Singapore, Nuevocor specializes in creating genetic medicines for untreatable genetic cardiomyopathies by leveraging insights from our PrOSIA mechanobiology platform.
Who invested in Nuevocor Pte.
10 investors across 3 rounds
See all investors in Nuevocor Pte.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nuevocor Pte.
Who invested in Nuevocor Pte.?
Nuevocor Pte. has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nuevocor Pte. raised?
Nuevocor Pte. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Nuevocor Pte. last raise money?
Nuevocor Pte.'s most recent round on record is a Series B, in Sep 2025.
What does Nuevocor Pte. do?
Founded in 2021 and based in Singapore, Nuevocor specializes in creating genetic medicines for untreatable genetic cardiomyopathies by leveraging insights from our PrOSIA mechanobiology platform.
Where is Nuevocor Pte. headquartered?
Nuevocor Pte. is headquartered in Singapore, Singapore.
Which VCs invest in companies like Nuevocor Pte.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Nuevocor Pte.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Nuevocor Pte.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.